image glp 1 GLP-1 Drug Side Effects May Be Tackled with More Mechanistic Studies 1 medications or looking for a natural alternative. GLP-1 Drugs and the Physiology

B., Oreskovic, I., Ziger, T., Novinscak, T., Krezic, I., Strbe, S., Drinkovic, M., Brkic, F., Popic, J., Skrtic, A., Seiwerth, S., Staresinic, M., Sikiric, P.,

In the SURMOUNT-1 trial, Tirzepatide produced average weight reductions of 15.0%, 19.5%, and 20.9% at weekly doses of 5 mg, 10 mg, and 15 mg respectively, over 72 weeks (Jastreboff et al., NEJM 2022

Duilio C, Ambrosio G, Kuppusamy P, Dipaula A, Becker LC, Zweier JL

Microsequence analysis of forms previously characterized by chromatographic methods

Mercken EM, Crosby SD, Dudley W, Jebailey L, Krzysik-Walker S, Villareal DT et al

Further investigations are imperative to discern L-carnitines clinical impacts on various patient demographics, identify factors contributing to L-carnitine unresponsiveness, and enable personalized treatment adjustments to optimize oocyte quality and fertility outcomes